TerrAscend (TSNDF) Return on Capital Employed Growth (1y) (2023 - 2026)
TerrAscend (TSNDF) Return on Capital Employed Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | TerrAscend | 197.99 Mn | 155.88 Mn | 36.25 Mn | 15.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.00 |
| Mar 31, 2026 | 57.00 |
| Dec 31, 2025 | 223.00 |
| Sep 30, 2025 | 450.00 |
| Jun 30, 2025 | 177.00 |
| Mar 31, 2025 | 101.00 |
| Dec 31, 2024 | 56.00 |
| Sep 30, 2024 | -1,259.00 |
| Jun 30, 2024 | 14,895.00 |
| Mar 31, 2024 | 6,635.00 |
| Dec 31, 2023 | 6,438.00 |
| Sep 30, 2023 | 6,666.00 |
| Jun 30, 2023 | -14,075.00 |
| Mar 31, 2023 | -6,107.00 |